Bomgaars Lisa, Carberry Kathleen, Fraser Charles, West Aaron, Teruya Jun
Department of Pediatrics, Hematology-Oncology Section, Baylor College of Medicine, Houston, TX 77030, USA.
Congenit Heart Dis. 2010 May-Jun;5(3):303-8. doi: 10.1111/j.1747-0803.2009.00344.x.
Factor V and thrombin inhibitors may develop following exposure to bovine thrombin preparations. In patient populations where exposure to bovine thrombin is common, such as children undergoing cardiovascular surgery, the development of such inhibitors should be considered in the evaluation of prolonged prothrombin times. We present three cases of children developing factor V and thrombin inhibitors following repeated exposure during cardiac surgical procedures.
接触牛凝血酶制剂后可能会产生Ⅴ因子和凝血酶抑制剂。在经常接触牛凝血酶的患者群体中,如接受心血管手术的儿童,在评估凝血酶原时间延长时应考虑此类抑制剂的产生。我们报告了3例儿童在心脏外科手术过程中反复接触后产生Ⅴ因子和凝血酶抑制剂的病例。